Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000700835 | SCV000829608 | likely benign | Hereditary sensory neuropathy-deafness-dementia syndrome | 2024-11-28 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001531881 | SCV001747197 | likely benign | not provided | 2023-09-01 | criteria provided, single submitter | clinical testing | DNMT1: BP4, BS1 |
Genetic Services Laboratory, |
RCV001815008 | SCV002061946 | uncertain significance | not specified | 2021-11-23 | criteria provided, single submitter | clinical testing | This sequence change does not appear to have been previously described in individuals with DNMT1-related disorders. This sequence change has been described in the gnomAD database with a frequency of 0.036% in the African/African American subgroup (dbSNP rs369196079). The p.Arg101Trp change affects a poorly conserved amino acid residue located in a domain of the DNMT1 protein that is known to be functional. In-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL) provide contradictory results for the p.Arg101Trp substitution. Due to insufficient evidence and the lack of functional studies, the clinical significance of the p.Arg101Trp change remains unknown at this time. |
Ambry Genetics | RCV002440510 | SCV002753065 | likely benign | Inborn genetic diseases | 2021-06-23 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |